Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®/Taclonex®) in the treatment of psoriasis vulgaris

K Kragballe; J Austad; L Barnes; A Bibby; M. de la Brassinne; F Cambazard; C Fleming; Hannele Heikkilä; Z Williams; J Peyri Rey; Å Svensson; J Toole; G Wozel

Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®/Taclonex®) in the treatment of psoriasis vulgaris

K Kragballe
, J Austad
, L Barnes
, A Bibby
, M. de la Brassinne
, F Cambazard
, C Fleming
, Hannele Heikkilä
, Z Williams
, J Peyri Rey
, Å Svensson
, J Toole
, G Wozel

Kliniken för hud- och könssjukdomar

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Dermatology
Volym	213
Nummer	4
Sidor (från-till)	319-326
Antal sidor	8
ISSN	1018-8665
Status	Publicerad - 2006
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

Citera det här

Kragballe, K., Austad, J., Barnes, L., Bibby, A., Brassinne, M. D. L., Cambazard, F., Fleming, C., Heikkilä, H., Williams, Z., Peyri Rey, J., Svensson, Å., Toole, J., & Wozel, G. (2006). Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®/Taclonex®) in the treatment of psoriasis vulgaris. Dermatology, 213(4), 319-326.

@article{cfd1c949cf3d415180d7df01f1fc6db3,

title = "Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet{\textregistered}/Dovobet{\textregistered}/Taclonex{\textregistered}) in the treatment of psoriasis vulgaris",

keywords = "3121 General medicine, internal medicine and other clinical medicine",

author = "K Kragballe and J Austad and L Barnes and A Bibby and Brassinne, \{M. de la\} and F Cambazard and C Fleming and Hannele Heikkil{\"a} and Z Williams and \{Peyri Rey\}, J and {\AA} Svensson and J Toole and G Wozel",

year = "2006",

language = "English",

volume = "213",

pages = "319--326",

journal = "Dermatology",

issn = "1018-8665",

publisher = "S. Karger AG",

number = "4",

}

Kragballe, K, Austad, J, Barnes, L, Bibby, A, Brassinne, MDL, Cambazard, F, Fleming, C, Heikkilä, H, Williams, Z, Peyri Rey, J, Svensson, Å, Toole, J & Wozel, G 2006, 'Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®/Taclonex®) in the treatment of psoriasis vulgaris', Dermatology, vol. 213, nr. 4, s. 319-326.

Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®/Taclonex®) in the treatment of psoriasis vulgaris. / Kragballe, K; Austad, J; Barnes, L et al.
I: Dermatology, Vol. 213, Nr. 4, 2006, s. 319-326.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®/Taclonex®) in the treatment of psoriasis vulgaris

AU - Kragballe, K

AU - Austad, J

AU - Barnes, L

AU - Bibby, A

AU - Brassinne, M. de la

AU - Cambazard, F

AU - Fleming, C

AU - Heikkilä, Hannele

AU - Williams, Z

AU - Peyri Rey, J

AU - Svensson, Å

AU - Toole, J

AU - Wozel, G

PY - 2006

Y1 - 2006

KW - 3121 General medicine, internal medicine and other clinical medicine

M3 - Article

SN - 1018-8665

VL - 213

SP - 319

EP - 326

JO - Dermatology

JF - Dermatology

IS - 4

ER -